O

OrbiMed Portfolio holdings

AUM $4.59B
1-Year Est. Return 131.45%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+131.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.89B
AUM Growth
+$717M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
126
New
Increased
Reduced
Closed

Top Buys

1 +$41.7M
2 +$37.3M
3 +$33.5M
4
HELP
Cybin Inc
HELP
+$24.7M
5
BRKR icon
Bruker
BRKR
+$23.5M

Top Sells

1 +$125M
2 +$65.8M
3 +$51.6M
4
AXSM icon
Axsome Therapeutics
AXSM
+$38.9M
5
SIBN icon
SI-BONE Inc
SIBN
+$38M

Sector Composition

1 Healthcare 99.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAPT
26
DELISTED
RAPT Therapeutics
RAPT
$55.6M 1.14%
1,642,891
+556,273
CRVS icon
27
Corvus Pharmaceuticals
CRVS
$1.04B
$55.2M 1.13%
7,165,006
UTHR icon
28
United Therapeutics
UTHR
$23.6B
$51.3M 1.05%
105,200
-9,700
ABVX
29
Abivax
ABVX
$10.6B
$49.6M 1.02%
367,900
-12,100
ROIV icon
30
Roivant Sciences
ROIV
$21.6B
$47.5M 0.97%
2,190,907
-523,891
CRNX icon
31
Crinetics Pharmaceuticals
CRNX
$3.75B
$46.5M 0.95%
999,000
-100,000
AXSM icon
32
Axsome Therapeutics
AXSM
$12.1B
$46.2M 0.95%
253,121
-278,679
EYPT icon
33
EyePoint Inc
EYPT
$1.14B
$45.1M 0.92%
2,468,314
+672,314
RNAM
34
DELISTED
Avidity Biosciences
RNAM
$44.7M 0.91%
619,530
-1,019,356
NBIX icon
35
Neurocrine Biosciences
NBIX
$15.9B
$44.6M 0.91%
314,240
-39,400
DYN icon
36
Dyne Therapeutics
DYN
$3.2B
$43.1M 0.88%
2,202,184
-112,000
BMY icon
37
Bristol-Myers Squibb
BMY
$117B
$41.8M 0.86%
+775,000
PFE icon
38
Pfizer
PFE
$149B
$41.2M 0.84%
+1,652,900
TRVI icon
39
Trevi Therapeutics
TRVI
$2.01B
$39.9M 0.82%
3,190,700
-117,700
NPCE icon
40
Neuropace
NPCE
$564M
$37.2M 0.76%
2,406,335
-207,849
ASND icon
41
Ascendis Pharma A/S
ASND
$13.8B
$36.7M 0.75%
171,977
-19,928
EXAS
42
DELISTED
Exact Sciences
EXAS
$35.7M 0.73%
351,716
-642,900
MLYS icon
43
Mineralys Therapeutics
MLYS
$2.6B
$35.6M 0.73%
980,400
-489,094
ELV icon
44
Elevance Health
ELV
$85.4B
$34.7M 0.71%
+99,100
FBRX icon
45
Forte Biosciences
FBRX
$391M
$32.6M 0.67%
1,196,955
PRLD icon
46
Prelude Therapeutics
PRLD
$312M
$31.6M 0.65%
10,909,256
HELP
47
Cybin Inc
HELP
$227M
$31.4M 0.64%
+3,840,500
ORIC icon
48
Oric Pharmaceuticals
ORIC
$875M
$29.8M 0.61%
3,641,756
KRYS icon
49
Krystal Biotech
KRYS
$9.11B
$29.5M 0.6%
119,800
+17,055
PRAX icon
50
Praxis Precision Medicines
PRAX
$9.76B
$27.9M 0.57%
+94,500